TRIMEDYNE INC

Trimedyne Inc., operating within the Electromedical & Electrotherapeutic Apparatus sector governed by SIC 3841, designs and delivers wearable therapeutic devices and monitoring systems that help acute-care hospitals and specialty rehabilitation clinics manage chronic pain, neuromuscular conditions, and post-surgical recovery. The company pairs its proprietary hardware with analytics-rich software to support physicians, physical therapists, and intensity-managed care programs in tailoring electrotherapy regimens while tracking compliance and outcomes for insurers. Core offerings emphasize portability, patient comfort, and seamless data feeds to electronic medical records, allowing Trimedyne to serve both outpatient and inpatient providers seeking evidence-based adjunctive therapies. Material risks include the need to maintain FDA clearances for medical device classifications, navigate third-party reimbursement policy shifts, and control supply chain costs for microprocessor-led components; the company must also brace for scrutiny around durable medical equipment audits and evolving telehealth rules. The most recent SEC disclosure is a Form 10-K filed December 1998, and CIK 357001 anchors the company’s public identity. See live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025